Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024
Seres Therapeutics (Nasdaq: MCRB), a leading live biotherapeutics company, has announced that it will host a conference call and live audio webcast on August 13, 2024, at 8:30 a.m. ET to discuss its second quarter 2024 financial results and provide business updates. Investors and interested parties can access the conference call by dialing 800-715-9871 (domestic) or 646-307-1963 (international) and referencing the conference ID number 4877586. A live webcast will be available in the 'Investors and News' section of the Seres website, with a replay accessible approximately two hours after the event and archived for about 21 days.
Seres Therapeutics (Nasdaq: MCRB), una delle principali aziende di bioterapie a base di microflora, ha annunciato che ospiterà una conferenza telefonica e un webcast audio live il 13 agosto 2024, alle 8:30 ET per discutere i risultati finanziari del secondo trimestre 2024 e fornire aggiornamenti aziendali. Gli investitori e le parti interessate possono accedere alla conferenza telefonica componendo il numero 800-715-9871 (nazionale) o 646-307-1963 (internazionale) e facendo riferimento al numero di identificazione della conferenza 4877586. Un webcast in diretta sarà disponibile nella sezione 'Investitori e Notizie' del sito web di Seres, con una registrazione accessibile circa due ore dopo l'evento e archiviata per circa 21 giorni.
Seres Therapeutics (Nasdaq: MCRB), una de las principales empresas de bioterapias vivas, ha anunciado que llevará a cabo una llamada de conferencia y una transmisión en vivo de audio el 13 de agosto de 2024, a las 8:30 a.m. ET para discutir sus resultados financieros del segundo trimestre de 2024 y proporcionar actualizaciones comerciales. Los inversores y las partes interesadas pueden acceder a la llamada de conferencia marcando 800-715-9871 (nacional) o 646-307-1963 (internacional) y haciendo referencia al número de identificación de la conferencia 4877586. Una transmisión en vivo estará disponible en la sección 'Inversores y Noticias' del sitio web de Seres, con una repetición accesible aproximadamente dos horas después del evento y archivada durante unos 21 días.
세레스 테라퓨틱스 (Nasdaq: MCRB), 선도적인 생물 치료제 회사가 2024년 8월 13일 오전 8시 30분 ET에 두 번째 분기 2024 재무 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 컨퍼런스 콜 및 라이브 오디오 웹캐스트를 개최한다고 발표했습니다. 투자자 및 관심 있는 당사자는 800-715-9871 (국내) 또는 646-307-1963 (국제)에 전화하여 컨퍼런스 ID 번호 4877586을 참조하여 이 컨퍼런스 콜에 액세스할 수 있습니다. 라이브 웹캐스트는 세레스 웹사이트의 '투자자 및 뉴스' 섹션에서 제공되며, 이벤트 발생 약 2시간 후에 재생 가능하며 약 21일 동안 아카이브됩니다.
Seres Therapeutics (Nasdaq: MCRB), une entreprise leader dans le secteur des biothérapies vivantes, a annoncé qu'elle organisera une conférence téléphonique et un webinaire audio en direct le 13 août 2024 à 8h30 ET pour discuter de ses résultats financiers du deuxième trimestre 2024 et fournir des mises à jour commerciales. Les investisseurs et les parties intéressées peuvent accéder à la conférence téléphonique en composant le 800-715-9871 (national) ou le 646-307-1963 (international) et en se référant au numéro d'identification de la conférence 4877586. Un webinaire en direct sera disponible dans la section 'Investisseurs et Nouvelles' du site Web de Seres, avec un replay accessible environ deux heures après l'événement et archivé pendant environ 21 jours.
Seres Therapeutics (Nasdaq: MCRB), ein führendes Unternehmen im Bereich lebender Biotherapeutika, hat angekündigt, dass es am 13. August 2024 um 8:30 Uhr ET eine Telefonkonferenz und einen Live-Audio-Webcast abhalten wird, um die Finanzergebnisse des zweiten Quartals 2024 zu erörtern und Unternehmensupdates bereitzustellen. Investoren und Interessierte können die Telefonkonferenz unter der Nummer 800-715-9871 (national) oder 646-307-1963 (international) erreichen und auf die Konferenz-ID-Nummer 4877586 verweisen. Ein Live-Webcast wird im Abschnitt 'Investoren und Nachrichten' auf der Website von Seres verfügbar sein, mit einer Wiederholung, die etwa zwei Stunden nach der Veranstaltung zugänglich ist und etwa 21 Tage lang archiviert wird.
- None.
- None.
CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on August 13, 2024 at 8:30 a.m. ET to discuss second quarter 2024 financial results and provide business updates.
To access the conference call, please dial 800-715-9871 (domestic) or 646-307-1963 (international) and reference the conference ID number 4877586. To join the live webcast, please visit the “Investors and News” section of the Seres website at www.serestherapeutics.com.
A webcast replay will be available on the Seres website beginning approximately two hours after the event and will be archived for approximately 21 days.
About Seres Therapeutics
Seres Therapeutics, Inc. (Nasdaq: MCRB) is a clinical-stage biotechnology company focused on improving patient outcomes in medically vulnerable populations through the use of oral cultivated live biotherapeutics. Seres led the successful development and approval of VOWST™, the first FDA-approved orally administered microbiome therapeutic. The Company is evaluating SER-155 in a Phase 1b study in patients receiving allogeneic hematopoietic stem cell transplantation. SER-155 is designed to prevent gastrointestinal (GI)-derived infections and resulting bloodstream infections, enhance epithelial barrier integrity, and induce immune tolerance responses to reduce the incidence of graft-versus-host-disease (GvHD). The Company is also advancing additional cultivated oral microbiome therapeutics for medically vulnerable populations, including those with chronic liver disease, cancer neutropenia, and solid organ transplants. For more information, please visit www.serestherapeutics.com.
Investor and Media Contacts:
IR@serestherapeutics.com
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com
FAQ
When will Seres Therapeutics (MCRB) release its Q2 2024 financial results?
How can investors access Seres Therapeutics' (MCRB) Q2 2024 earnings call?
What time is Seres Therapeutics' (MCRB) Q2 2024 earnings call scheduled for?
Where can I find the replay of Seres Therapeutics' (MCRB) Q2 2024 earnings webcast?
